Market News & Analysis

Top Story

Idea of the Day: Why Goldman Sachs could benefit from Treasury yield revival

What: Goldman Sachs has been the weakest performers’ out of the major US banks this year, however things could be about to change for this Investment bank.  Firstly, the recent rise in US Treasury yields, is very good news for investment banks’ fixed income units, particularly Goldman Sachs’, which suffered a heavy decline in profit for the second quarter of this year. US 10 – year Treasury yields have risen some 14 basis points since tanking on Friday, and the expectation is for further gains in the coming weeks. This is particularly relevant for Goldman Sachs, since the short-term correlation between the bank and 10-year US Treasury yields is a whopping 93%. Secondly, global banks along with insurers have seen expectations for 2017 lifted with upgrades to earnings outweighing cuts by the largest margin since 2009, which should also benefit the share price of the overall banking sector.

How: As you can see in chart one below, Goldman has moved in line with the Treasury yields for most of this year, in the last two months the correlation between Goldman’s stock price and Treasury yields has been nearly 80%, thus, where Treasury yields go, so to, it appears, does Goldman Sachs’ stock price. If we see a continued recovery in Treasury yields, Goldman may play catch up to its peers, as you can see in chart 2 below. Goldman Sachs has been the weakest performer vs. Citi, JP Morgan and Bank of America, which has been the top performer out of the major US banks.

Chart 1: 

Source: City Index and Bloomberg

Chart 2: 

Source: City Index and Bloomberg

Join our live webinars for the latest analysis and trading ideas. Register now

From time to time, GAIN Capital Limited’s (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.